Brooke Levis1, Andrea Benedetti2, John P A Ioannidis3, Ying Sun4, Zelalem Negeri1, Chen He4, Yin Wu5, Ankur Krishnan4, Parash Mani Bhandari1, Dipika Neupane1, Mahrukh Imran4, Danielle B Rice6, Kira E Riehm7, Nazanin Saadat4, Marleine Azar1, Jill Boruff8, Pim Cuijpers9, Simon Gilbody10, Lorie A Kloda11, Dean McMillan12, Scott B Patten13, Ian Shrier14, Roy C Ziegelstein15, Sultan H Alamri16, Dagmar Amtmann17, Liat Ayalon18, Hamid R Baradaran19, Anna Beraldi20, Charles N Bernstein21, Arvin Bhana22, Charles H Bombardier17, Gregory Carter23, Marcos H Chagas24, Dixon Chibanda25, Kerrie Clover23, Yeates Conwell26, Crisanto Diez-Quevedo27, Jesse R Fann28, Felix H Fischer29, Leila Gholizadeh30, Lorna J Gibson31, Eric P Green32, Catherine G Greeno33, Brian J Hall34, Emily E Haroz35, Khalida Ismail36, Nathalie Jetté37, Mohammad E Khamseh38, Yunxin Kwan39, Maria Asunción Lara40, Shen-Ing Liu41, Sonia R Loureiro24, Bernd Löwe42, Ruth Ann Marrie43, Laura Marsh44, Anthony McGuire45, Kumiko Muramatsu46, Laura Navarrete47, Flávia L Osório48, Inge Petersen49, Angelo Picardi50, Stephanie L Pugh51, Terence J Quinn52, Alasdair G Rooney53, Eileen H Shinn54, Abbey Sidebottom55, Lena Spangenberg56, Pei Lin Lynnette Tan39, Martin Taylor-Rowan57, Alyna Turner58, Henk C van Weert59, Paul A Vöhringer60, Lynne I Wagner61, Jennifer White62, Kirsty Winkley63, Brett D Thombs64. 1. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada. 2. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada. 3. Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. 4. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada. 5. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada. 6. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada. 7. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. 8. Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montréal, Québec, Canada. 9. Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. 10. Hull York Medical School and the Department of Health Sciences, University of York, Heslington, NY, UK. 11. Library, Concordia University, Montréal, Québec, Canada. 12. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. 13. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada. 14. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Family Medicine, McGill University, Montréal, Québec, Canada. 15. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 16. Faculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia. 17. Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA. 18. Louis and Gabi Weisfeld School of Social Work, Bar Ilan University, Ramat Gan, Israel. 19. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran; Ageing Clinical & Experimental Research Team, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK. 20. Kbo-Lech-Mangfall-Klinik Garmisch-Partenkirchen, Klinik für Psychiatrie, Psychotherapie & Psychosomatik, Lehrkrankenhaus der Technischen Universität München, Munich, Germany. 21. University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. 22. Centre for Rural Health, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa. 23. Centre for Brain and Mental Health Research, University of Newcastle, New South Wales, Australia. 24. Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. 25. Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe. 26. Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA. 27. Servei de Psiquiatria, Hospital Germans Trias i Pujol, Badalona, Spain; Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Badalona, Spain. 28. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA. 29. Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany. 30. Faculty of Health, University of Technology Sydney, Sydney, Australia. 31. Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. 32. Duke Global Health Institute, Duke University, Durham, NC, USA. 33. School of Social Work, University of Pittsburgh, Pittsburgh, PA, USA. 34. Department of Psychology, Faculty of Social Sciences, Global and Community Mental Health Research Group, University of Macau, Macau Special Administrative Region, China; Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 35. Center for American Indian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 36. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurosciences, King's College London Weston Education Centre, London, UK. 37. Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 38. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran. 39. Department of Psychological Medicine, Tan Tock Seng Hospital, Singapore. 40. Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. San Lorenzo Huipulco, Tlalpan, México D. F. Mexico. 41. Programme in Health Services & Systems Research, Duke-NUS Medical School, Singapore; Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medicine, Mackay Medical College, Taipei, Taiwan. 42. Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 43. Departments of Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. 44. Baylor College of Medicine, Houston and Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA. 45. Department of Nursing, St. Joseph's College, Standish, ME, USA. 46. Department of Clinical Psychology, Graduate School of Niigata Seiryo University, Niigata, Japan. 47. Department of Epidemiology and Psychosocial Research, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico. 48. Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil; National Institute of Science and Technology, Translational Medicine, Ribeirão Preto, Brazil. 49. Centre for Rural Health, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. 50. Centre for Behavioural Sciences and Mental Health, Italian National Institute of Health, Rome, Italy. 51. NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; American College of Radiology, Philadelphia, PA, USA. 52. Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, Scotland, UK. 53. Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburg, Edinburgh, Scotland, UK. 54. Department of Behavioral Science, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. 55. Allina Health, Minneapolis, MN, USA. 56. Department of Medical Psychology and Medical Sociology, University of Leipzig, Leipzig, Germany. 57. Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, Scotland, UK. 58. School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia; Deakin University, IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Geelong, Victoria, Australia. 59. Department of General Practice, Amsterdam Institute for General Practice and Public Health, Amsterdam University Medical Centers, Location AMC, Amsterdam, the Netherlands. 60. Department of Psychiatry and Mental Health, Clinical Hospital, Universidad de Chile, Santiago, Chile; Millennium Institute for Depression and Personality Research (MIDAP), Ministry of Economy, Macul, Santiago, Chile; Psychiatry Department, Tufts Medical Center, Tufts University, Boston, MA, USA. 61. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, NC, USA; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA. 62. Department of Physiotherapy, School of Primary and Allied Health Care, Monash University, Melbourne, Australia. 63. Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King's College London, London, UK. 64. Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada; Department of Educational and Counselling Psychology, McGill University, Montréal, Québec, Canada; Biomedical Ethics Unit, McGill University, Montréal, Québec, Canada. Electronic address: brett.thombs@mcgill.ca.
Abstract
OBJECTIVES: Depression symptom questionnaires are not for diagnostic classification. Patient Health Questionnaire-9 (PHQ-9) scores ≥10 are nonetheless often used to estimate depression prevalence. We compared PHQ-9 ≥10 prevalence to Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID) major depression prevalence and assessed whether an alternative PHQ-9 cutoff could more accurately estimate prevalence. STUDY DESIGN AND SETTING: Individual participant data meta-analysis of datasets comparing PHQ-9 scores to SCID major depression status. RESULTS: A total of 9,242 participants (1,389 SCID major depression cases) from 44 primary studies were included. Pooled PHQ-9 ≥10 prevalence was 24.6% (95% confidence interval [CI]: 20.8%, 28.9%); pooled SCID major depression prevalence was 12.1% (95% CI: 9.6%, 15.2%); and pooled difference was 11.9% (95% CI: 9.3%, 14.6%). The mean study-level PHQ-9 ≥10 to SCID-based prevalence ratio was 2.5 times. PHQ-9 ≥14 and the PHQ-9 diagnostic algorithm provided prevalence closest to SCID major depression prevalence, but study-level prevalence differed from SCID-based prevalence by an average absolute difference of 4.8% for PHQ-9 ≥14 (95% prediction interval: -13.6%, 14.5%) and 5.6% for the PHQ-9 diagnostic algorithm (95% prediction interval: -16.4%, 15.0%). CONCLUSION: PHQ-9 ≥10 substantially overestimates depression prevalence. There is too much heterogeneity to correct statistically in individual studies.
OBJECTIVES: Depression symptom questionnaires are not for diagnostic classification. Patient Health Questionnaire-9 (PHQ-9) scores ≥10 are nonetheless often used to estimate depression prevalence. We compared PHQ-9 ≥10 prevalence to Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID) major depression prevalence and assessed whether an alternative PHQ-9 cutoff could more accurately estimate prevalence. STUDY DESIGN AND SETTING: Individual participant data meta-analysis of datasets comparing PHQ-9 scores to SCID major depression status. RESULTS: A total of 9,242 participants (1,389 SCID major depression cases) from 44 primary studies were included. Pooled PHQ-9 ≥10 prevalence was 24.6% (95% confidence interval [CI]: 20.8%, 28.9%); pooled SCID major depression prevalence was 12.1% (95% CI: 9.6%, 15.2%); and pooled difference was 11.9% (95% CI: 9.3%, 14.6%). The mean study-level PHQ-9 ≥10 to SCID-based prevalence ratio was 2.5 times. PHQ-9 ≥14 and the PHQ-9 diagnostic algorithm provided prevalence closest to SCID major depression prevalence, but study-level prevalence differed from SCID-based prevalence by an average absolute difference of 4.8% for PHQ-9 ≥14 (95% prediction interval: -13.6%, 14.5%) and 5.6% for the PHQ-9 diagnostic algorithm (95% prediction interval: -16.4%, 15.0%). CONCLUSION: PHQ-9 ≥10 substantially overestimates depression prevalence. There is too much heterogeneity to correct statistically in individual studies.
Authors: Pedro H Manfro; Rivka B Pereira; Martha Rosa; Hugo Cogo-Moreira; Helen L Fisher; Brandon A Kohrt; Valeria Mondelli; Christian Kieling Journal: Eur Child Adolesc Psychiatry Date: 2021-12-02 Impact factor: 4.785
Authors: Philip Hyland; Frédérique Vallières; Mark Shevlin; Richard P Bentall; Sarah Butter; Todd K Hartman; Thanos Karatzias; Anton P Martinez; Orla McBride; Jamie Murphy; Robert Fox Journal: Epidemiol Psychiatr Sci Date: 2022-07-01 Impact factor: 7.818
Authors: Ruth Ann Marrie; Lesley A Graff; John D Fisk; Scott B Patten; Charles N Bernstein Journal: Inflamm Bowel Dis Date: 2021-07-27 Impact factor: 5.325
Authors: Leoné Malan; Mark Hamer; Roland von Känel; Konstantin Kotliar; Roelof D van Wyk; Gavin W Lambert; Walthard Vilser; Tjalf Ziemssen; Markus P Schlaich; Wayne Smith; Martin Magnusson; Annemarie Wentzel; Carlien E Myburgh; Hendrik S Steyn; Nico T Malan Journal: Cardiovasc J Afr Date: 2020-10-26 Impact factor: 1.167
Authors: Mélissa Généreux; Philip J Schluter; Elsa Landaverde; Kevin Kc Hung; Chi Shing Wong; Catherine Pui Yin Mok; Gabriel Blouin-Genest; Tracey O'Sullivan; Marc D David; Marie-Eve Carignan; Olivier Champagne-Poirier; Nathalie Pignard-Cheynel; Sébastien Salerno; Grégoire Lits; Leen d'Haenens; David De Coninck; Koenraad Matthys; Eric Champagne; Nathalie Burlone; Zeeshan Qadar; Teodoro Herbosa; Gleisse Ribeiro-Alves; Ronald Law; Virginia Murray; Emily Ying Yang Chan; Mathieu Roy Journal: Int J Environ Res Public Health Date: 2021-05-01 Impact factor: 3.390
Authors: Emily N Satinsky; Tomoki Kimura; Mathew V Kiang; Rediet Abebe; Scott Cunningham; Hedwig Lee; Xiaofei Lin; Cindy H Liu; Igor Rudan; Srijan Sen; Mark Tomlinson; Miranda Yaver; Alexander C Tsai Journal: Sci Rep Date: 2021-07-13 Impact factor: 4.379
Authors: Brett D Thombs; Brooke Levis; Anita Lyubenova; Dipika Neupane; Zelalem Negeri; Yin Wu; Ying Sun; Chen He; Ankur Krishnan; Simone N Vigod; Parash Mani Bhandari; Mahrukh Imran; Danielle B Rice; Marleine Azar; Matthew J Chiovitti; Nazanin Saadat; Kira E Riehm; Jill T Boruff; Pim Cuijpers; Simon Gilbody; John P A Ioannidis; Lorie A Kloda; Scott B Patten; Ian Shrier; Roy C Ziegelstein; Liane Comeau; Nicholas D Mitchell; Marcello Tonelli; Jacqueline Barnes; Cheryl Tatano Beck; Carola Bindt; Barbara Figueiredo; Nadine Helle; Louise M Howard; Jane Kohlhoff; Zoltán Kozinszky; Angeliki A Leonardou; Sandra Nakić Radoš; Chantal Quispel; Tamsen J Rochat; Alan Stein; Robert C Stewart; Meri Tadinac; S Darius Tandon; Iva Tendais; Annamária Töreki; Thach D Tran; Kylee Trevillion; Katherine Turner; Johann M Vega-Dienstmaier; Andrea Benedetti Journal: Can J Psychiatry Date: 2020-10-26 Impact factor: 4.356